MFG Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
19,446
-126
-0.6% -$7.24K 0.8% 59
2026
Q1
$1.19M Sell
19,572
-584
-3% -$34K 0.98% 55
2025
Q4
$1.09M Buy
+20,156
New +$970K 0.85% 52
2025
Q1
Sell
-30,397
Closed -$1.72M 60
2024
Q4
$1.72M Buy
+30,397
New +$1.7M 1.58% 32

Other funds holding BMY

MFG Wealth Management's BMY Position: Q2 2026 in Review

MFG Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.64% in Q2 2026, selling an estimated $7.24K and leaving 19,446 shares worth $1.12M. The position accounts for 0.8% of the portfolio, ranked #59.

MFG Wealth Management first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.72M in Q4 2024. 565 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MFG Wealth Management held 19,446 shares of Bristol-Myers Squibb worth $1.12M as of Q2 2026.
  • MFG Wealth Management sold 126 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.24K.
  • Bristol-Myers Squibb made up 0.8% of MFG Wealth Management's portfolio in Q2 2026, its #59 holding.
  • MFG Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
  • MFG Wealth Management's Bristol-Myers Squibb position peaked at $1.72M in Q4 2024.
  • 565 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MFG Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.